Klebsiella pneumoniae LPS drives stromal-mediated repression of p53 and colorectal cancer chemoresistance

Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clin. 2024;74:229–63.

Google Scholar 

Eng C, Yoshino T, Ruiz-García E, Mostafa N, Cann CG, O’Brian B, et al. Colorectal cancer. Lancet. 2024;404:294–310.

Article 
CAS 
PubMed 

Google Scholar 

Lehouritis P, Cummins J, Stanton M, Murphy CT, McCarthy FO, Reid G, et al. Local bacteria affect the efficacy of chemotherapeutic drugs. Sci Rep. 2015;5:14554.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Geller LT, Barzily-Rokni M, Danino T, Jonas OH, Shental N, Nejman D, et al. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science. 2017;357:1156–60.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Li H-L, Lu L, Wang X-S, Qin L-Y, Wang P, Qiu S-P, et al. Alteration of Gut microbiota and inflammatory cytokine/chemokine profiles in 5-fluorouracil induced intestinal mucositis. Front Cell Infect Microbiol. 2017;7:455.

Article 
PubMed 
PubMed Central 

Google Scholar 

Yu T, Guo F, Yu Y, Sun T, Ma D, Han J, et al. Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy. Cell. 2017;170:548–63.e16.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Zhang S, Yang Y, Weng W, Guo B, Cai G, Ma Y, et al. Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal cancer. J Exp Clin Cancer Res. 2019;38:1–13.

Google Scholar 

Wang N, Zhang L, Leng X-X, Xie Y-L, Kang Z-R, Zhao L-C, et al. Fusobacterium nucleatum induces chemoresistance in colorectal cancer by inhibiting pyroptosis via the Hippo pathway. Gut Microbes. 2024;16:2333790.

Article 
PubMed 
PubMed Central 

Google Scholar 

Colbert LE, El Alam MB, Wang R, Karpinets T, Lo D, Lynn EJ, et al. Tumor-resident Lactobacillus iners confer chemoradiation resistance through lactate-induced metabolic rewiring. Cancer Cell. 2023;41:1945–62.e11.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Routy B, Lenehan JG, Miller WH, Jamal R, Messaoudene M, Daisley BA, et al. Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial. Nat Med. 2023;29:2121–32.

Article 
CAS 
PubMed 

Google Scholar 

Lee WS, Lee SJ, Lee HJ, Yang H, Go E-J, Gansukh E, et al. Oral reovirus reshapes the gut microbiome and enhances antitumor immunity in colon cancer. Nat Commun. 2024;15:9092.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

El Tekle G, Garrett WS. Bacteria in cancer initiation, promotion and progression. Nat Rev Cancer. 2023;23:600–18.

Article 
CAS 
PubMed 

Google Scholar 

Galeano Niño JL, Wu H, LaCourse KD, Kempchinsky AG, Baryiames A, Barber B, et al. Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer. Nature. 2022;611:810–7.

Article 
PubMed 
PubMed Central 

Google Scholar 

Peuget S, Zhou X, Selivanova G. Translating p53-based therapies for cancer into the clinic. Nat Rev Cancer. 2024;24:192–215.

Article 
CAS 
PubMed 

Google Scholar 

Robles AI, Jen J, Harris CC. Clinical outcomes of TP53 mutations in cancers. Cold Spring Harb Perspect Med. 2016;6:a026294.

Article 
PubMed 
PubMed Central 

Google Scholar 

Yang B, Eshleman JR, Berger NA, Markowitz SD. Wild-type p53 protein potentiates cytotoxicity of therapeutic agents in human colon cancer cells. Clin Cancer Res. 1996;2:1649–57.

CAS 
PubMed 

Google Scholar 

Ablain J, Poirot B, Esnault C, Lehmann-Che J, de Thé H. p53 as an effector or inhibitor of therapy response. Cold Spring Harb Perspect Med. 2015;6:a026260.

Article 
PubMed 
PubMed Central 

Google Scholar 

Wei J, Noto J, Zaika E, Romero-Gallo J, Correa P, El-Rifai W, et al. Pathogenic bacterium Helicobacter pylori alters the expression profile of p53 protein isoforms and p53 response to cellular stresses. Proc Natl Acad Sci USA. 2012;109:E2543–50.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Bergounioux J, Elisee R, Prunier A-L, Donnadieu F, Sperandio B, Sansonetti P, et al. Calpain activation by the Shigella flexneri effector VirA regulates key steps in the formation and life of the bacterium’s epithelial niche. Cell Host Microbe. 2012;11:240–52.

Article 
CAS 
PubMed 

Google Scholar 

Siegl C, Rudel T. Modulation of p53 during bacterial infections. Nat Rev Microbiol. 2015;13:741–8.

Article 
CAS 
PubMed 

Google Scholar 

Kadosh E, Snir-Alkalay I, Venkatachalam A, May S, Lasry A, Elyada E, et al. The gut microbiome switches mutant p53 from tumour-suppressive to oncogenic. Nature. 2020;586:133–8.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Wu Y-J, Xiong J-F, Zhan C-N, Xu H. Gut microbiota alterations in colorectal adenoma-carcinoma sequence based on 16S rRNA gene sequencing: a systematic review and meta-analysis. Micro Pathog. 2024;195:106889.

Article 
CAS 

Google Scholar 

de Waal GM, de Villiers WJS, Forgan T, Roberts T, Pretorius E. Colorectal cancer is associated with increased circulating lipopolysaccharide, inflammation and hypercoagulability. Sci Rep. 2020;10:8777.

Article 
PubMed 
PubMed Central 

Google Scholar 

Huang W-K, Chang JW-C, See L-C, Tu H-T, Chen J-S, Liaw C-C, et al. Higher rate of colorectal cancer among patients with pyogenic liver abscess with Klebsiella pneumoniae than those without: an 11-year follow-up study. Colorectal Dis. 2012;14:e794–801.

Article 
PubMed 

Google Scholar 

Aschtgen M-S, Fragkoulis K, Sanz G, Normark S, Selivanova G, Henriques-Normark B, et al. Enterobacteria impair host p53 tumor suppressor activity through mRNA destabilization. Oncogene. 2022;41:2173–86.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin AA, Kim S, et al. The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature. 2012;483:603–7.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Weintraub A, Zähringer U, Wollenweber HW, Seydel U, Rietschel ET. Structural characterization of the lipid A component of Bacteroides fragilis strain NCTC 9343 lipopolysaccharide. Eur J Biochem. 1989;183:425–31.

Article 
CAS 
PubMed 

Google Scholar 

Liberzon A, Birger C, Thorvaldsdóttir H, Ghandi M, Mesirov JP, Tamayo P. The molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1:417–25.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Fischer M, Grossmann P, Padi M, DeCaprio JA. Integration of TP53, DREAM, MMB-FOXM1 and RB-E2F target gene analyses identifies cell cycle gene regulatory networks. Nucleic Acids Res. 2016;44:6070–86.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Tissot C, Mechti N. Molecular cloning of a new interferon-induced factor that represses human immunodeficiency virus type 1 long terminal repeat expression. J Biol Chem. 1995;270:14891–8.

Article 
CAS 
PubMed 

Google Scholar 

Obad S, Brunnström H, Vallon-Christersson J, Borg A, Drott K, Gullberg U. Staf50 is a novel p53 target gene conferring reduced clonogenic growth of leukemic U-937 cells. Oncogene. 2004;23:4050–9.

Article 
CAS 
PubMed 

Google Scholar 

Truntzer C, Isambert N, Arnould L, Ladoire S, Ghiringhelli F. Prognostic value of transcriptomic determination of tumour-infiltrating lymphocytes in localised breast cancer. Eur J Cancer. 2019;120:97–106.

Article 
CAS 
PubMed 

Google Scholar 

Ottaiano A, Santorsola M, Capuozzo M, Perri F, Circelli L, Cascella M, et al. The prognostic role of p53 mutations in metastatic colorectal cancer: a systematic review and meta-analysis. Crit Rev Oncol/Hematol. 2023;186:104018.

Article 
PubMed 

Google Scholar 

Nunes L, Li F, Wu M, Luo T, Hammarström K, Torell E, et al. Prognostic genome and transcriptome signatures in colorectal cancers. Nature. 2024;633:137–46.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Boyer J, McLean EG, Aroori S, Wilson P, McCulla A, Carey PD, et al. Characterization of p53 wild-type and null isogenic colorectal cancer cell lines resistant to 5-fluorouracil, oxaliplatin, and irinotecan. Clin Cancer Res. 2004;10:2158–67.

Article 
CAS 
PubMed 

Google Scholar 

Michel M, Kaps L, Maderer A, Galle PR, Moehler M. The role of p53 dysfunction in colorectal cancer and its implications for therapy. Cancers. 2021;13:2296.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Mitchell RA, Liao H, Chesney J, Fingerle-Rowson G, Baugh J, David J, et al. Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc Natl Acad Sci USA. 2002;99:345–50.

Article 
CAS 
PubMed 

Google Scholar 

Brighenti E, Calabrese C, Liguori G, Giannone FA, Trerè D, Montanaro L, et al. Interleukin 6 downregulates p53 expression and activity by stimulating ribosome biogenesis: a new pathway connecting inflammation to cancer. Oncogene. 2014;33:4396–406.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Cheteh EH, Sarne V, Ceder S, Bianchi J, Augsten M, Rundqvist H, et al. Interleukin-6 derived from cancer-associated fibroblasts attenuates the p53 response to doxorubicin in prostate cancer cells. Cell Death Discov. 2020;6:42.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Moyer SM, Wasylishen AR, Qi Y, Fowlkes N, Su X, Lozano G. p53 drives a transcriptional program that elicits a non-cell-autonomous response and alters cell state in vivo. Proc Natl Acad Sci USA. 2020;117:23663–73.

Article 
PubMed 
PubMed Central 

Google Scholar 

Ahnen DJ, Feigl P, Quan G, Fenoglio-Preiser C, Lovato LC, Bunn PA, et al. Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study. Cancer Res. 1998;58:1149–58.

CAS 
PubMed 

Google Scholar 

Martínez-Jiménez F, Movasati A, Brunner SR, Nguyen L, Priestley P, Cuppen E, et al. Pan-cancer whole-genome comparison of primary and metastatic solid tumours. Nature. 2023;618:333–41.

Article 
PubMed 
PubMed Central 

Google Scholar 

Donehower LA, Soussi T, Korkut A, Liu Y, Schultz A, Cardenas M, et al. Integrated analysis of TP53 gene and pathway alterations in the Cancer Genome Atlas. Cell Rep. 2019;28:1370–84.e5.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Bertheau P, Plassa F, Espié M, Turpin E, de Roquancourt A, Marty M, et al. Effect of mutated TP53 on response of advanced breast cancers to high-dose chemotherapy. Lancet. 2002;360:852–4.

Article 
CAS 
PubMed 

Google Scholar 

Martinez-Rivera M, Siddik ZH. Resistance and gain-of-resistance phenotypes in cancers harboring wild-type p53. Biochem Pharmacol. 2012;83:1049–62.

Article 
CAS 
PubMed 

Google Scholar 

Cutty SJ, Hughes FA, Ortega-Prieto P, Desai S, Thomas P, Fets LV, et al. Pro-survival roles for p21(Cip1/Waf1) in non-small cell lung cancer. Br J Cancer. 2025;132:421–37.

Article 
CAS 
PubMed 

Google Scholar 

Krishnaraj J, Yamamoto T, Ohki R. p53-dependent cytoprotective mechanisms behind resistance to chemo-radiotherapeutic agents used in cancer treatment. Cancers. 2023;15:3399.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Williams DS, Mouradov D, Browne C, Palmieri M, Elliott MJ, Nightingale R, et al. Overexpression of the TP53 protein is associated with the lack of adjuvant chemotherapy benefit in patients with stage III colorectal cancer. Mod Pathol. 2020;33:483–95.

Article 
CAS 
PubMed 

Google Scholar 

Dai J, Su Y, Zhong S, Cong L, Liu B, Yang J, et al. Exosomes: key players in cancer and potential therapeutic strategy. Sig Transduct Target Ther. 2020;5:1–10.

Article 

Google Scholar 

van Niel G, D’Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018;19:213–28.

Article 
PubMed 

Google Scholar 

Zhu X, Shen H, Yin X, Yang M, Wei H, Chen Q, et al. Macrophage-derived exosomes deliver miR-223 to epithelial ovarian cancer cells to elicit a chemoresistant phenotype. J Exp Clin Cancer Res. 2019;38:81.

Article 
PubMed 
PubMed Central 

Google Scholar 

Yin Z, Ma T, Huang B, Lin L, Zhou Y, Yan J, et al. Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-β signaling pathway. J Exp Clin Cancer Res. 2019;38:310.

Article 
PubMed 
PubMed Central 

Google Scholar 

Kolfschoten IGM, van Leeuwen B, Berns K, Mullenders J, Beijersbergen RL, Bernards R, et al. A genetic screen identifies PITX1 as a suppressor of RAS activity and tumorigenicity. Cell. 2005;121:849–58.

Article 
CAS 
PubMed 

Google Scholar 

Peuget S, Zhu J, Sanz G, Singh M, Gaetani M, Chen X, et al. Thermal proteome profiling identifies oxidative-dependent inhibition of the transcription of major oncogenes as a new therapeutic mechanism for select anticancer compounds. Cancer Res. 2020;80:1538–50.

Article 
CAS 
PubMed 

Google Scholar 

Saei AA, Beusch CM, Chernobrovkin A, Sabatier P, Zhang B, Tokat ÜG, et al. ProTargetMiner is a proteome signature library of anticancer molecules for functional discovery. Nat Commun. 2019;10:5715.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Saei AA, Lundin A, Lyu H, Gharibi H, Luo H, Teppo J, et al. Multifaceted proteome analysis at solubility, redox, and expression dimensions for target identification. Adv Sci. 2024;11:e2401502.

Article 

Google Scholar 

Reimand J, Arak T, Adler P, Kolberg L, Reisberg S, Peterson H, et al. g: profiler-a web server for functional interpretation of gene lists (2016 update). Nucleic Acids Res. 2016;44:W83–89.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498–504.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Reimand J, Isserlin R, Voisin V, Kucera M, Tannus-Lopes C, Rostamianfar A, et al. Pathway enrichment analysis and visualization of omics data using g: profiler, GSEA, Cytoscape and Enrichmentmap. Nat Protoc. 2019;14:482–517.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102:15545–50.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2:401–4.

Article 
PubMed 
PubMed Central 

Google Scholar 

Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 2013; 6: pl1.

Barbie DA, Tamayo P, Boehm JS, Kim SY, Moody SE, Dunn IF, et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature. 2009;462:108–12.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Vizcaíno JA, Deutsch EW, Wang R, Csordas A, Reisinger F, Ríos D, et al. ProteomeXchange provides globally coordinated proteomics data submission and dissemination. Nat Biotechnol. 2014;32:223–6.

Article 
PubMed 
PubMed Central 

Google Scholar